ImmunityBio

2.62
+0.14
+5.87%
IBRX
高 2.65开 2.53量 756.37万股总市值 25.76亿
低 2.52换 0.77%额 1947.93万市盈TTM 亏损
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
讨论
资讯
公告
资料
财务
相关
用户头像
ImmunityBio(IBRX)
10-21 05:35  
$ImmunityBio(IBRX)$ DEF 14C Other definitive information statements Accession Number: 0001326110-25-000129  Act: 34  Size: 175 KB 网页链接
用户头像
ImmunityBio(IBRX)
10-09 05:05  
$ImmunityBio(IBRX)$ PRE 14C Other preliminary information statements Accession Number: 0001326110-25-000124  Act: 34  Size: 174 KB 网页链接
用户头像
ImmunityBio(IBRX)
08-09 04:35  
$ImmunityBio(IBRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-25-177024  Act: 34  Size: 641 KB 网页链接
用户头像
ImmunityBio(IBRX)
08-05 19:45  
$ImmunityBio(IBRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001326110-25-000114  Act: 34  Size: 15 MB 网页链接
用户头像
ImmunityBio(IBRX)
08-05 19:25  
$ImmunityBio(IBRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001326110-25-000112  Act: 34  Size: 299 KB 网页链接
用户头像
ImmunityBio(IBRX)
07-28 23:15  
$ImmunityBio(IBRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-165807  Act: 33  Size: 916 KB 网页链接
用户头像
ImmunityBio(IBRX)
07-25 18:25  
$ImmunityBio(IBRX)$ 8-K Current report, items 1.01, 2.02, 7.01, 8.01, and 9.01 Accession Number: 0001193125-25-164789  Act: 34  Size: 764 KB 网页链接
1赞
用户头像
ImmunityBio(IBRX)
06-24 05:15  
$ImmunityBio(IBRX)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001326110-25-000099  Act: 33  Size: 273 KB 网页链接
用户头像
ImmunityBio(IBRX)
06-21 06:45  
$ImmunityBio(IBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001326110-25-000094  Size: 5 KB 网页链接
用户头像
ImmunityBio(IBRX)
06-21 06:45  
$ImmunityBio(IBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001326110-25-000093  Size: 5 KB 网页链接
用户头像
ImmunityBio(IBRX)
06-21 06:45  
$ImmunityBio(IBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001326110-25-000092  Size: 5 KB 网页链接
用户头像
ImmunityBio(IBRX)
06-21 06:35  
$ImmunityBio(IBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001326110-25-000090  Size: 5 KB 网页链接
用户头像
ImmunityBio(IBRX)
06-21 06:35  
$ImmunityBio(IBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001326110-25-000091  Size: 5 KB 网页链接
用户头像
ImmunityBio(IBRX)
06-21 04:45  
$ImmunityBio(IBRX)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001326110-25-000084  Act: 34  Size: 415 KB 网页链接
用户头像
ImmunityBio(IBRX)
05-12 18:55  
$ImmunityBio(IBRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001326110-25-000071  Act: 34  Size: 14 MB 网页链接
2转发 · 2讨论
用户头像
ImmunityBio(IBRX)
05-12 18:45  
$ImmunityBio(IBRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001326110-25-000069  Act: 34  Size: 265 KB 网页链接
用户头像
ImmunityBio(IBRX)
05-05 19:25  
$ImmunityBio(IBRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-25-112057  Act: 34  Size: 428 KB 网页链接
用户头像
ImmunityBio(IBRX)
04-30 18:05  
$ImmunityBio(IBRX)$ DEF 14A Other definitive proxy statements Accession Number: 0001326110-25-000054  Act: 34  Size: 7 MB 网页链接
用户头像
ImmunityBio(IBRX)
04-30 18:05  
$ImmunityBio(IBRX)$ ARS Annual Report to Security Holders Accession Number: 0001326110-25-000056  Act: 34  Size: 113 MB 网页链接
用户头像
ImmunityBio(IBRX)
04-30 18:05  
$ImmunityBio(IBRX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001326110-25-000059  Act: 34  Size: 432 KB 网页链接